Designing Sustainable High Performance in Business-to-Business Collaborations

Today’s Line Managers

PRECISION MEDICINE

Apoferritin as a Nanocarrier

Drug Substance Scale-up

Artificial Intelligence

DIGITAL TECHNOLOGY IN PHARMA

BIG DATA AND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MANUFACTURING

PHARMA LOGISTICS TRENDS

Get instant access to latest e-book

LATEST NEWSRead more...

25

Jun 2019

Gilead and Carna Biosciences Announce Research and Development Collaboration to Develop Novel Immuno-Oncology Therapies

Gilead Sciences Inc and Carna Biosciences Inc today announced that the companies have entered into a research and development collaboration to develop and commercialize small molecule compounds in immunooncology and to access Carnas proprietary lipid kinase drug discovery platform

25

Jun 2019

C4X Discovery and PhoreMost collaboration to accelerate Parkinson’s Disease drug discovery pipeline

CX Discovery Holdings plc a pioneering drug discovery company today entered into a collaboration with PhoreMost a UKbased biopharmaceutical company dedicated to drugging undruggable disease targets The collaboration focused initially in Parkinsons Disease will combine both companys technology platfo...

24

Jun 2019

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-APOC3

Arrowhead Pharmaceuticals Inc announced that the US Food and Drug Administration FDA has granted orphan drug designation to AROAPOC for the treatment of familial chylomicronemia syndrome FCS There is no currently available therapy in the US that can adequately treat FCS

21

Jun 2019

WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing

WuXi Biologics a leading global openaccess biologics technology platform company offering endtoend solutions for biologics discovery development and manufacturing announced that it planned to expand the new stateoftheart integrated biologics conjugation solution center to include commercial manufact...

20

Jun 2019

Ultragenyx and Arcturus Therapeutics Expand Existing Research Collaboration and License Agreement

Ultragenyx Pharmaceutical Inc a biopharmaceutical company focused on the development of novel products for serious rare and ultrarare genetic diseases and Arcturus Therapeutics Holdings Inc a leading messenger RNA medicines company today announced that they have expanded their collaboration to disco...

press releasesRead more...

25

Jun 2019

CPhI series reporting successful first half to 2019

The CPhI global pharma event series part of Informa Markets Health Nutrition business continues to surge ahead in with its global editions securing increased visitor and exhibitor numbers The events successes have harnessed the trend towards increased outsourcing in the pharma supply chain and h...

25

Jun 2019

Minerva Biotechnologies Announces FDA Acceptance of IND Application for huMNC2-CAR44 T cells to Treat Metastatic Breast Cancer

Minerva Biotechnologies a biopharmaceutical company focused on developing immunotherapies for cancer and cellular therapies in regenerative medicine announced today that the US FDA Food and Drug Administration has approved their IND Investigational New Drug application to conduct clinical trials wit...

25

Jun 2019

FDA Approves New Drug Application for Vyleesi™ (bremelanotide injection)

HSDD is the most common type of female sexual dysfunction in the US The condition is characterized by low sexual desire and marked distress which are not attributable to existing medical pharmacologic psychiatric or relationship issuesApproximately million premenopausal women meet the diagnosis cri...

24

Jun 2019

Prestige BioPharma Reports Positive Top-Line Phase III Results for Tuznue® (Trastuzumab Biosimilar)

Prestige BioPharma herein Prestige today announced positive topline results from a Phase III global clinical trial Troika evaluating the efficacy safety and pharmacokinetics PK of biosimilar candidate HD to Herceptin trastuzumab

24

Jun 2019

Clinigen Broadens Partnership with Accord Healthcare to Supply and Distribute Cardioxane® and Savene® in Poland

Clinigen Group plc the global pharmaceutical and services company announces that its Commercial Medicines business has signed an exclusive agreement with Accord Healthcare Accord to supply and distribute Clinigens speciality medicines Cardioxane and Savene in Poland

EventsRead more...

24 - 26

Jun 2019

Digital Pharma West 2019

Hyatt Regency San Francisco Airport

24 - 25

Jun 2019

10th Summit on Biosimilars

New York Marriott East Side Hotel

25 - 27

Jun 2019

2nd CPLM Summit

Hanson Wade
Hyatt Regency Boston

26 - 28

Jun 2019

4th Microbiome Movement - Drug Development Summit

Microbiome Movement
Revere Hotel Boston Common

AirBridgeCargo - Air frieght solutions for your Pharma

KNOWLEDGE BANK

Interviews

Merck

Staff Engineer, Manufacturing Science and Technology, South East Asia
Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...

Articles

Sunlight Assisted Degradation of Waste Chemicals Green Technology for Pharmaceutical Waste Management

For the last few decades the earth is suffering from many environmental problems like global warming water pollution and water scarcity waste disposal and land degradation and management etc Out of these problems recently waste management

Research Insights

Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine

Abstract Background Inflammatory breast cancer IBC is a rare aggressive form of breast cancer associated with HER amplification with high risk of metastasis and an estimated median survival of y We performed an openlabel singlearm phase II clinical trial ClinicalTrialsgov NCT to in

Case Studies

Rapid, Comprehensive, And Aff Ordable Mycobacterial Diagnosis With Whole-genome Sequencing: A Prospective Case Study

Abstract Background Slow and cumbersome laboratory diagnostics for Mycobacterium tuberculosis complex MTBC risk delayed treatment and poor patient outcomes Wholegenome sequencing WGS could potentially provide a rapid and comprehensive diagnostic solution In this prospective study we compare realtime

Techno Trends

UW–Madison School of Pharmacy Designs New Compounds to Fight Deadly Mosquito-Transmitted Viruses

UWMadison school of Pharmacy designed a breakthrough in creating new small molecules that penetrate into the brain where the virus resides and interfere with viral replication to stop Equine Encephalitis Viruses EEV

White Papers

Launching Global Clinical Trials—best Practices For Efficient And Cost-effective Translations: A Lionsbridge White Paper

Summary The target market for conducting global clinical trials has changed significantly moving beyond pharmaceutical early adopters to the mainstream marketplace This shift has placed a heightened focus on the language challenges and complexity of running a global clinical trial More and more companies are moving toward

Advisory Board

Stella

Sanjoy Ray

Rustom

Phil

Neil J

Laurence

Kenneth I

Georg C

Frank A

Douglas

Christopher-

Alan S Louie

EDITORIAL SECTION

STRATEGY

ETHICAL BUSINESS STIMULATES BEST VALUE IN HEALTH ECONOMY

Seventy years ago average life expectancy globally was today it is Seventy years ago million people worldwide were infected with smallpox today non...

RESEARCH DEVELOPMENT

Academic Ventures and Professional Service Companies

Over the past few decades life science and pharma have been characterised by a series of radical changes that have been at the origin of an impressive...

CLINICAL TRIALS

Speed, Quality and Cost

In recent years the pharmaceutical industry has seen tremendous changes in the way it is expected to deliver new drugs to market being under increasin...

MANUFACTURING

CLINICAL MANUFACTURING ON TIME AND WITHIN BUDGET

The key to successfully developing and shepherding a drug to the approval stage and beyond lies in careful planning right from the start of developmen...

Information Technology

CUSTOMER CENTRICITY ON SOCIAL MEDIA

Imagine checking into a hotel late in the night but not being able to get the room you had so carefully chosen because the call centre didnt align wit...

EXPERT Talk

How SMEs Can Achieve Regulatory Compliance through a Risk-Based Approach

What is the current consensus on the ICH E R Addendum within SMEs The complexity and size of clinical trials has intensified over recent years alo...

Designing Sustainable High Performance in Business-to-Business Collaborations

Today’s Line Managers

PRECISION MEDICINE

Apoferritin as a Nanocarrier

Drug Substance Scale-up

Artificial Intelligence

DIGITAL TECHNOLOGY IN PHARMA

BIG DATA AND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MANUFACTURING

PHARMA LOGISTICS TRENDS

Get instant access to latest e-book

LATEST NEWSRead more...

25

Gilead and Carna Biosciences Announce Research and Development Collaboration to Develop Novel Immuno-Oncology Therapies

25

C4X Discovery and PhoreMost collaboration to accelerate Parkinson’s Disease drug discovery pipeline

24

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-APOC3

21

WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing

20

Ultragenyx and Arcturus Therapeutics Expand Existing Research Collaboration and License Agreement

press releasesRead more...

25

CPhI series reporting successful first half to 2019

25

Minerva Biotechnologies Announces FDA Acceptance of IND Application for huMNC2-CAR44 T cells to Treat Metastatic Breast Cancer

25

FDA Approves New Drug Application for Vyleesi™ (bremelanotide injection)

24

Prestige BioPharma Reports Positive Top-Line Phase III Results for Tuznue® (Trastuzumab Biosimilar)

24

Clinigen Broadens Partnership with Accord Healthcare to Supply and Distribute Cardioxane® and Savene® in Poland

EventsRead more...

24 - 26

Digital Pharma West 2019

24 - 25

10th Summit on Biosimilars

25 - 27

2nd CPLM Summit

26 - 28

4th Microbiome Movement - Drug Development Summit

Advertisements

TOP ARTICLES

1

Ligand Decorated Theranostic Nanomedicines

2

Industry 4.0: A Closed Micronisation System

3

Nanomedicines management for advance therapy of NeuroAIDS: State of art

4

Mock-up in The Design Stage - FPS’s particular attention

5

MicroRNA (miRNA) in Nanostructure Lipid Carriers based Tumor Gene Therapy

KNOWLEDGE BANK

Merck

Sunlight Assisted Degradation of Waste Chemicals Green Technology for Pharmaceutical Waste Management

Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine

Rapid, Comprehensive, And Aff Ordable Mycobacterial Diagnosis With Whole-genome Sequencing: A Prospective Case Study

UW–Madison School of Pharmacy Designs New Compounds to Fight Deadly Mosquito-Transmitted Viruses

Launching Global Clinical Trials—best Practices For Efficient And Cost-effective Translations: A Lionsbridge White Paper

Advisory Board

EDITORIAL SECTION

ETHICAL BUSINESS STIMULATES BEST VALUE IN HEALTH ECONOMY

Academic Ventures and Professional Service Companies

Speed, Quality and Cost

CLINICAL MANUFACTURING ON TIME AND WITHIN BUDGET

CUSTOMER CENTRICITY ON SOCIAL MEDIA

How SMEs Can Achieve Regulatory Compliance through a Risk-Based Approach